Evidence map›Paper›PMID 31277504›Full record

ArticleToxins2019

A Short Peptide Derived from the ZorO Toxin Functions as an Effective Antimicrobial.

Yuichi Otsuka, Tomohiro Ishikawa, Chisato Takahashi, Michiaki Masuda

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mechanism of action ofFrontiers in microbiology · 2023
    Article
  5. Article
  6. Review
  7. TheToxins · 2021
    Article
  8. Review
  9. Improved growth ofJournal of bacteriology · 2021
    Article
  10. Journal of fungi (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yuichi OtsukaDepartment of Biochemistry and Molecular Biology, Graduate School of Science and Engineering, Saitama University, 255 Shimo-Okubo, Sakura-Ku, Saitama City, Saitama 388-8570, Japan. otsukay@mail.saitama-u.ac.jp.
Tomohiro IshikawaDepartment of Microbiology, School of Medicine, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan.
Chisato TakahashiDepartment of Microbiology, School of Medicine, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan.
Michiaki MasudaDepartment of Microbiology, School of Medicine, Dokkyo Medical University, 880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan.
Dokkyo Medical University · JPSaitama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides are potential molecules for the development of novel antibiotic agents. The ZorO toxin of a type I toxin-antitoxin system in

Indexed as

AnimalsAnti-Infective AgentsBacillus subtilisBacterial ToxinsCandida albicansCell LineCell MembraneCell SurvivalChlorocebus aethiopsCricetinaeEscherichia coliEscherichia coli ProteinsOligopeptidesStaphylococcus aureusAnti-Infective AgentsBacterial ToxinsEscherichia coli ProteinsOligopeptidesZorO protein, E coliantimicrobial peptideToxin–Antitoxin systemZorO

Identifiers

PMID31277504
PMCPMC6669753
OpenAlexW2954156833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.